Status:
COMPLETED
Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in Thailand
Lead Sponsor:
Mahidol University
Conditions:
COVID-19
Eligibility:
All Genders
12+ years
Brief Summary
The investigators assessed the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation.
Detailed Description
The investigators aimed to assess the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation. The investigators compared the population between the age groups ...
Eligibility Criteria
Inclusion
- patient with infected with the novel coronavirus disease 2019 (COVID-19) who has been end of self-quarantine at Siriraj Hospital more than 21 days.
- Thai nationality, able to read and write Thai language
- able to use telephone and line to communicate
Exclusion
- 1\. people who received additional vaccination after leaving quarantine before the day of the immunization test
Key Trial Info
Start Date :
November 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 20 2022
Estimated Enrollment :
5181 Patients enrolled
Trial Details
Trial ID
NCT05328479
Start Date
November 4 2021
End Date
May 20 2022
Last Update
October 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok Noi, Bangkok, Thailand, 10700